Agatha Jassem
#87,739
Most Influential Person Now
Researcher
Agatha Jassem's AcademicInfluence.com Rankings
Agatha Jassemcomputer-science Degrees
Computer Science
#12971
World Rank
#13909
Historical Rank
Computational Linguistics
#3246
World Rank
#3290
Historical Rank
Machine Learning
#6000
World Rank
#6100
Historical Rank
Artificial Intelligence
#6464
World Rank
#6581
Historical Rank
Download Badge
Computer Science
Agatha Jassem's Degrees
- Masters Computer Science Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Agatha Jassem Influential?
(Suggest an Edit or Addition)According to Wikipedia, Agatha Jassem is a Canadian clinical microbiologist and the program head of the Virology Lab at the British Columbia Centre for Disease Control Public Health Laboratory, and a clinical assistant professor in the Department of Pathology & Laboratory Medicine at the University of British Columbia in Vancouver, British Columbia, Canada.
Agatha Jassem's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018 (2018) (81)
- Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada (2021) (79)
- Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017 (2017) (63)
- Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV) (2019) (44)
- Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018 (2018) (41)
- Mapping SARS-CoV-2 antigenic relationships and serological responses (2022) (40)
- In Vitro Susceptibility of Burkholderia vietnamiensis to Aminoglycosides (2011) (39)
- Clinical Performance of Check-Direct CPE, a Multiplex PCR for Direct Detection of bla KPC, bla NDM and/or bla VIM, and bla OXA-48 from Perirectal Swabs (2015) (38)
- Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including P.1 and B.1.1.7 variants: a test-negative design in adults 70 years and older in British Columbia, Canada (2021) (28)
- A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2 (2021) (27)
- Escherichia albertii and Hafnia alvei are candidate enteric pathogens with divergent effects on intercellular tight junctions. (2008) (26)
- Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010–2011 to 2016–2017 (2020) (25)
- COVID-19 in an Immunocompromised Host: Persistent Shedding of Viable SARS-CoV-2 and Emergence of Multiple Mutations, a Case Report. (2021) (24)
- Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020 (2020) (23)
- Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada (2021) (23)
- Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness? (2018) (19)
- Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January–April 2021 (2021) (17)
- Investigation of aminoglycoside resistance inducing conditions and a putative AmrAB-OprM efflux system in Burkholderia vietnamiensis (2014) (14)
- Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016–2017 and 2017–2018 Epidemics in Canada (2020) (13)
- The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada (2021) (13)
- A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval (2021) (12)
- Assessing oligonucleotide designs from early lab developed PCR diagnostic tests for SARS-CoV-2 using the PCR_strainer pipeline (2020) (12)
- Evaluation of the clinical and analytical performance of the Seegene allplex™ SARS-CoV-2 variants I assay for the detection of variants of concern (VOC) and variants of interests (VOI) (2021) (11)
- Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens (2021) (10)
- A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG (2021) (9)
- Diagnostic Yield of Laboratory Methods and Value of Viral Genotyping during an Outbreak of Mumps in a Partially Vaccinated Population in British Columbia, Canada (2018) (9)
- TARGETED RESEQUENCING OF WETLAND SEDIMENT AS A TOOL FOR AVIAN INFLUENZA VIRUS SURVEILLANCE (2019) (9)
- Characterization of Clostridium difficile Strains in British Columbia, Canada: A Shift from NAP1 Majority (2008) to Novel Strain Types (2013) in One Region (2016) (9)
- Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: possible cohort effect following the 2009 influenza pandemic (2019) (8)
- Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada (2022) (7)
- Extraction and Detection of Avian Influenza Virus From Wetland Sediment Using Enrichment-Based Targeted Resequencing (2020) (6)
- Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks (2022) (6)
- Comparative single-dose mRNA and ChAdOx1 vaccine effectiveness against SARS-CoV-2, including early variants of concern: a test-negative design, British Columbia, Canada (2021) (6)
- Optimizing SARS-CoV-2 Variant of Concern Screening: Experience from British Columbia, Canada, Early 2021 (2021) (5)
- The Relationship Between Anti-Spike SARS-CoV-2 Antibody Levels and Risk of Breakthrough COVID-19 Among Fully Vaccinated Adults (2022) (5)
- Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response (2022) (5)
- HIV serology signal-to-cutoff ratio as a rapid method to predict confirmation of HIV infection (2018) (4)
- Evaluation of the Performance of a Multiplexed Serological Assay in the Detection of SARS-CoV-2 Infections in a Predominantly Vaccinated Population (2022) (4)
- Influenza Classification Suite: An automated Galaxy workflow for rapid influenza sequence analysis (2020) (4)
- Optimization of magnetic bead-based nucleic acid extraction for SARS-CoV-2 testing using readily available reagents (2021) (4)
- FilmArray respiratory panel assay: An effective method for detecting viral and atypical bacterial pathogens in bronchoscopy specimens (2019) (4)
- Pooled Nucleic Acid Amplification Test for Screening of Stool Specimens for Shiga Toxin-Producing Escherichia coli (2016) (3)
- The Contrasting Role of Nasopharyngeal Angiotensin Converting Enzyme 2 (ACE2) Expression in SARS-CoV-2 Infection: A Cross-Sectional Study of People Tested for COVID-19 in British Columbia (2020) (3)
- Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada (2022) (3)
- Identification of synergists that potentiate the action of polymyxin B against Burkholderia cenocepacia. (2015) (3)
- Development and validation of a real-time, reverse transcription PCR assay for rapid and low-cost genotyping of hepatitis C virus genotypes 1a, 1b, 2, and 3a. (2017) (3)
- BioFire FilmArray Decreases Infection Control Isolation Times by 4 days in ICU, BMT and Respiratory Wards (2017) (2)
- Influence of chronic hepatitis C infection on the monocyte-to-platelet ratio: data analysis from the National Health and Nutrition Examination Survey (2009–2016) (2021) (2)
- Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort Study (2022) (2)
- Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada (2022) (2)
- Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23 (2023) (2)
- Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination? (2022) (1)
- Comprehensive Immune Profiling of a Kidney Transplant Recipient With Peri-Operative SARS-CoV-2 Infection: A Case Report (2021) (1)
- Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008–2019 (2020) (1)
- Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273 (2022) (1)
- Investigation of aminoglycoside resistance inducing conditions and a putative AmrAB-OprM efflux system in Burkholderia vietnamiensis (2014) (1)
- Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals (2022) (1)
- Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada (2022) (1)
- Simple approximation of sample size for precise estimates of SARS-CoV-2 infection from point-seroprevalence studies (2022) (1)
- Population SARS-CoV-2 Seroprevalence Using Antenatal Serum Samples in British Columbia, Canada (2021) (1)
- Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Measure SARS-CoV-2 Humoral Immunogenicity (2021) (1)
- Comparative evaluation of the Aptima HSV 1&2 assay and a lab developed real-time PCR test for detection of HSV-1 and HSV-2 viruses (2016) (0)
- Frequency of prenatal hepatitis C screening and diagnosis in British Columbia, 2008–2018 (2020) (0)
- Measles Lymphadenopathy in a Child With PFAPA Syndrome (2018) (0)
- AMINOGLYCOSIDE SUSCEPTIBILITY AND ACQUIRED RESISTANCE IN (2012) (0)
- Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity (2022) (0)
- A case of mumps-associated myocarditis (2018) (0)
- Comparison of longitudinal SARS-CoV-2 nasopharyngeal specimens reveals the transcriptomic COVIDome (2021) (0)
- Erratum for Nikiforuk et al., “Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response” (2022) (0)
- Aminoglycoside susceptibility and acquired resistance in Burkholderia vietnamiensis (2012) (0)
- Nasopharyngeal Angiotensin Converting Enzyme 2 (ACE2) Expression as a Risk-Factor for SARS-CoV-2 Transmission in Concurrent Hospital Associated Outbreaks (2023) (0)
- Prediction of SARS-CoV-2 transmission dynamics based on population-level cycle threshold values: A Machine learning and mechanistic modeling study (2023) (0)
- vietnamiensis to Aminoglycosides Susceptibility of Burkholderia In Vitro (2014) (0)
- Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination in British Columbia, Canada: a Prospective Cohort Study (2022) (0)
- Informative Use of Cycle-Threshold Values to Account for Sampling Variability in Pathogen Detection (2023) (0)
- HIV serology signal-to-cutoff ratio as a rapid method to predict confirmation of HIV infection (2018) (0)
This paper list is powered by the following services:
Other Resources About Agatha Jassem
What Schools Are Affiliated With Agatha Jassem?
Agatha Jassem is affiliated with the following schools:
